Benzinga | Sep 27, 2021 08:16AM EDT

Dar Bioscience Announces $309,614 NIH Grant Award To Support Development Of DARE-LARC1

Dar? Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced a Notice of Award of a grant from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD), a division of the National Institutes of Health (NIH), for $309,614. This grant will support the development of DARE-LARC1, Dar?'s investigational user-controlled, long-acting reversible contraceptive (LARC), and such funding is in addition to a separate unrelated grant award for this program of up to $48.95 million announced earlier this year.